At first glance, CME Group (CME) and Cummins (CMI) may seem like an unusual pairing. Both are widely followed, dividend-paying large caps that draw interest from institutional and individual investors. This comparison stands out because the two names reflect very different risk profiles: CME is a low-volatility financial infrastructure business, while CMI is a cyclical industrial tied to trucking, energy, and data-center power demand. From what I see, traders evaluating relative performance, market positioning, and risk-adjusted returns may find this side-by-side look useful when deciding where to allocate capital right now.
CME, or CME Group Inc., runs one of the world's largest derivatives marketplaces. It offers futures and options across interest rates, equities, foreign exchange, energy, agriculture, and metals, plus clearing and market data services. Its business gains from hedging demand and market volatility. In recent weeks, CME reported third-quarter revenue up 13% year over year to a record of roughly $1.74 billion, with adjusted diluted earnings per share rising to $3.02. Average daily volume reached a third-quarter record of about 29.4 million contracts, and market data revenue also hit a record. The company returned nearly $1 billion to shareholders through dividends and buybacks. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. CME shares have traded near the upper end of their 52-week range, supported by a very low beta of roughly 0.18.
CMI, or Cummins Inc., manufactures diesel and natural gas engines, power-generation systems, and related components, with increasing emphasis on data-center backup power. Market action has been volatile. After rising strongly in the first half of 2026 and reaching an all-time high, CMI shares have retraced significantly and now trade near the low end of their 52-week range. In its most recent quarterly report, Cummins posted revenue up 13% to about $9.4 billion and record EBITDA of roughly $1.8 billion. Results missed estimates, however, and the company trimmed its full-year revenue growth outlook due to weaker North American pickup-truck demand and supply-chain constraints, even as power-generation demand tied to data centers stayed strong.
The clearest contrast between these two stocks is structural. CME is an asset-light exchange operator with high margins and revenue that rises when markets become more active. Its main risks include regulatory changes, pressure on trading fees, and any sustained drop in market volatility. CMI, by contrast, is a capital-intensive industrial whose results depend on truck production, energy transition spending, and infrastructure investment, leaving it exposed to economic cycles, trade policy, and raw-material costs. On recent momentum, CME has shown steadier relative performance and trades near its highs, while CMI has experienced a sharp correction that pressures its near-term technical profile. Both pay dividends, but CME currently carries a notably higher yield and lower beta, while CMI offers a lower valuation multiple after its pullback.
Based on observable factors such as trend consistency, volatility, recent catalysts, and relative positioning, Tickeron's AI would likely favor CME at this juncture. CME has sustained record volume and revenue growth, maintains a very low beta, and trades near the top of its range, all of which point to a more stable, constructive trend. CMI retains a strong data-center growth narrative, but its recent guidance cut and sharp price decline introduce greater uncertainty and weaker near-term momentum. In probabilistic terms, CME presents the more favorable risk-reward and trend profile in the current market environment.
I often turn to Tickeron’s AI Trading Bots when I want to test automated strategies across different market conditions. The platform offers hundreds of bots that monitor thousands of tickers, and the Trending AI Robots section highlights those performing best right now. It lets me review signal frequency, trade history, and track records before deciding on an approach that fits my risk tolerance. This has helped me spot strategies that align with the steadier profile I see in names like CME.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CME saw its Momentum Indicator move above the 0 level on November 10, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 106 similar instances where the indicator turned positive. In 64 of the 106 cases, the stock moved higher in the following days. The odds of a move higher are at 60%.
The 10-day moving average for CME crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 46%.
Following a +1.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where CME advanced for three days, in 174 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.
The Aroon Indicator entered an Uptrend today. In 137 of 261 cases where CME Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
The 10-day RSI Indicator for CME moved out of overbought territory on November 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 19 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 47%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 30 of 68 cases where CME's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 44%.
The Moving Average Convergence Divergence Histogram (MACD) for CME turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 19 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 41%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CME declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.
CME broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 26 (best 1 - 100 worst), indicating outstanding price growth. CME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 33 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.147) is normal, around the industry mean (4.143). P/E Ratio (25.814) is within average values for comparable stocks, (19.659). CME's Projected Growth (PEG Ratio) (4.578) is very high in comparison to the industry average of (1.780). Dividend Yield (0.017) settles around the average of (0.017) among similar stocks. CME's P/S Ratio (14.535) is slightly higher than the industry average of (7.166).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of securities and commodity exchanges
Industry FinancialPublishingServices